Table of Contents

2019-2024 Global Anti-Infective Medications Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Anti-Infective Medications Consumption 2014-2024
  • 2.1.2 Anti-Infective Medications Consumption CAGR by Region
• 2.2 Anti-Infective Medications Segment by Type
  • 2.2.1 Antivirals
  • 2.2.2 Antibacterials
  • 2.2.3 Antifungals
• 2.3 Anti-Infective Medications Consumption by Type
  • 2.3.1 Global Anti-Infective Medications Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Anti-Infective Medications Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Anti-Infective Medications Sale Price by Type (2014-2019)
• 2.4 Anti-Infective Medications Segment by Application
  • 2.4.1 Hospital Pharmacies
  • 2.4.2 Online Pharmacies
  • 2.4.3 Retail Pharmacies
• 2.5 Anti-Infective Medications Consumption by Application
  • 2.5.1 Global Anti-Infective Medications Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Anti-Infective Medications Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Anti-Infective Medications Sale Price by Application (2014-2019)

3 Global Anti-Infective Medications by Players

• 3.1 Global Anti-Infective Medications Sales Market Share by Players
  • 3.1.1 Global Anti-Infective Medications Sales by Players (2017-2019)
  • 3.1.2 Global Anti-Infective Medications Sales Market Share by Players (2017-2019)
• 3.2 Global Anti-Infective Medications Revenue Market Share by Players
  • 3.2.1 Global Anti-Infective Medications Revenue by Players (2017-2019)
  • 3.2.2 Global Anti-Infective Medications Revenue Market Share by Players (2017-2019)
• 3.3 Global Anti-Infective Medications Sale Price by Players
• 3.4 Global Anti-Infective Medications Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Anti-Infective Medications Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Anti-Infective Medications Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Anti-Infective Medications by Regions

• 4.1 Anti-Infective Medications by Regions
  • 4.1.1 Global Anti-Infective Medications Consumption by Regions
  • 4.1.2 Global Anti-Infective Medications Value by Regions
• 4.2 Americas Anti-Infective Medications Consumption Growth
• 4.3 APAC Anti-Infective Medications Consumption Growth
• 4.4 Europe Anti-Infective Medications Consumption Growth
• 4.5 Middle East & Africa Anti-Infective Medications Consumption Growth

5 Americas

• 5.1 Americas Anti-Infective Medications Consumption by Countries
  • 5.1.1 Americas Anti-Infective Medications Consumption by Countries (2014-2019)
  • 5.1.2 Americas Anti-Infective Medications Value by Countries (2014-2019)
• 5.2 Americas Anti-Infective Medications Consumption by Type
• 5.3 Americas Anti-Infective Medications Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Anti-Infective Medications Consumption by Countries
  • 6.1.1 APAC Anti-Infective Medications Consumption by Countries (2014-2019)
  • 6.1.2 APAC Anti-Infective Medications Value by Countries (2014-2019)
• 6.2 APAC Anti-Infective Medications Consumption by Type
• 6.3 APAC Anti-Infective Medications Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Anti-Infective Medications by Countries
  • 7.1.1 Europe Anti-Infective Medications Consumption by Countries (2014-2019)
  • 7.1.2 Europe Anti-Infective Medications Value by Countries (2014-2019)
• 7.2 Europe Anti-Infective Medications Consumption by Type
• 7.3 Europe Anti-Infective Medications Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Anti-Infective Medications by Countries
  • 8.1.1 Middle East & Africa Anti-Infective Medications Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Anti-Infective Medications Value by Countries (2014-2019)
• 8.2 Middle East & Africa Anti-Infective Medications Consumption by Type
• 8.3 Middle East & Africa Anti-Infective Medications Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Anti-Infective Medications Distributors
• 10.3 Anti-Infective Medications Customer

11 Global Anti-Infective Medications Market Forecast

• 11.1 Global Anti-Infective Medications Consumption Forecast (2019-2024)
• 11.2 Global Anti-Infective Medications Forecast by Regions
  • 11.2.1 Global Anti-Infective Medications Forecast by Regions (2019-2024)
  • 11.2.2 Global Anti-Infective Medications Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Anti-Infective Medications Forecast by Type
• 11.8 Global Anti-Infective Medications Forecast by Application

12 Key Players Analysis

• 12.1 Abbott
  • 12.1.1 Company Details
  • 12.1.2 Anti-Infective Medications Product Offered
  • 12.1.3 Abbott Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Abbott News
• 12.2 Astellas Pharma
  • 12.2.1 Company Details
  • 12.2.2 Anti-Infective Medications Product Offered
  • 12.2.3 Astellas Pharma Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Astellas Pharma News
• 12.3 Bayer
  • 12.3.1 Company Details
  • 12.3.2 Anti-Infective Medications Product Offered
  • 12.3.3 Bayer Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Bayer News
• 12.4 Bristol-Myers Squibb
  • 12.4.1 Company Details
  • 12.4.2 Anti-Infective Medications Product Offered
  • 12.4.3 Bristol-Myers Squibb Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Bristol-Myers Squibb News
• 12.5 Daiichi Sankyo
  • 12.5.1 Company Details
  • 12.5.2 Anti-Infective Medications Product Offered
  • 12.5.3 Daiichi Sankyo Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Daiichi Sankyo News
• 12.6 GlaxoSmithKline
  • 12.6.1 Company Details
  • 12.6.2 Anti-Infective Medications Product Offered
  • 12.6.3 GlaxoSmithKline Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 GlaxoSmithKline News
• 12.7 Merck
  • 12.7.1 Company Details
  • 12.7.2 Anti-Infective Medications Product Offered
  • 12.7.3 Merck Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Merck News
• 12.8 Novartis
  • 12.8.1 Company Details
  • 12.8.2 Anti-Infective Medications Product Offered
  • 12.8.3 Novartis Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Novartis News
• 12.9 Pfizer
  • 12.9.1 Company Details
  • 12.9.2 Anti-Infective Medications Product Offered
  • 12.9.3 Pfizer Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Pfizer News
• 12.10 Roche
  • 12.10.1 Company Details
  • 12.10.2 Anti-Infective Medications Product Offered
  • 12.10.3 Roche Anti-Infective Medications Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Roche News

13 Research Findings and Conclusion

Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.

According to this study, over the next five years the Anti-Infective Medications market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anti-Infective Medications business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Infective Medications market by product type, application, key manufacturers and key regions and countries.

This study considers the Anti-Infective Medications value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Antivirals
Antibacterials
Antifungals
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott
Astellas Pharma
Bayer
Bristol-Myers Squibb
Daiichi Sankyo
GlaxoSmithKline
Merck
Novartis
Pfizer
Roche

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Anti-Infective Medications consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Anti-Infective Medications market by identifying its various subsegments.
Focuses on the key global Anti-Infective Medications manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-Infective Medications with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anti-Infective Medications submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.